The LINFU® U.S. Registry for the in the General Population Without Risk Factors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Graphic Novel for Patients Undergoing EUS-FNB
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC
- Status
- COMPLETED
- Phase
- N/A
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery
- Status
- COMPLETED
- Phase
- N/A
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CTS2190 Phase I /II Clinical Study in Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2